Nasdaq Stocks

The coronavirus pandemic may have confined techies worldwide to their homes but new initiatives are being taken to ensure that appropriate software are developed to undertake challenges that might pop up amid this lockdown. In fact, the World Health Organization (WHO) partnered

Humana Inc. HUM recently expanded the availability of telehealth services to reduce exposure to risks from the coronavirus outbreak. The World Health Organization-declared global pandemic already infected 375498 people to date across 196 countries or territories and took lives o

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Helen of Troy (HELE). This company, which is in the Zacks Cosmetics industry, shows potential f

Gol Linhas Aereas Inteligentes S.A. GOL will be suspending all international flights effective Mar 28 through May 3 as coronavirus concerns mount. Additionally, due to plummeting air travel demand, the airline will slash its domestic capacity by 92% for the same period.The carri

AngioDynamics (ANGO) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.

Coherent (COHR) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.

Quotient Technology (QUOT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.

TG Therapeutics (TGTX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.

AMAG Pharmaceuticals (AMAG) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock prices -- has triggered this rating change.

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, gr

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, gr

The Zacks Financial Transaction Services industry is part of the Financial Technology or FinTech space, which includes several companies with varying nature of businesses. The industry includes card and payment processors, ATM service providers, card payment solution providers,

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.

Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. However, when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.

Investors interested in Internet - Services stocks are likely familiar with Baidu Inc. (BIDU) and Shopify (SHOP). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 25th:

Investors in Emergent BioSolutions Inc (Symbol: EBS) saw new options become available this week, for the May 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the EBS options chain for the new May 15th contracts and identified one put a

Investors in Copa Holdings S.A. (Symbol: CPA) saw new options begin trading this week, for the November 20th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly tradi